Rps6ka2 Mouse 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of RPS6KA2 mRNA CTD PMID:17555576 Rps6ka2 Mouse 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPS6KA2 mRNA CTD PMID:17942748 Rps6ka2 Mouse 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of RPS6KA2 mRNA CTD PMID:17942748 Rps6ka2 Mouse 17beta-estradiol affects expression ISO RGD:1348784 6480464 Estradiol affects the expression of RPS6KA2 mRNA CTD PMID:14699072 Rps6ka2 Mouse 17beta-estradiol increases expression ISO RGD:1348784 6480464 Estradiol results in increased expression of RPS6KA2 mRNA CTD PMID:31614463 Rps6ka2 Mouse 17beta-estradiol multiple interactions ISO RGD:1348784 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of RPS6KA2 mRNA; [Estradiol co-treated more ... CTD PMID:20404318|PMID:30165855 Rps6ka2 Mouse 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPS6KA2 mRNA CTD PMID:17942748 Rps6ka2 Mouse 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:620676 6480464 Tetrachlorodibenzodioxin results in increased expression of RPS6KA2 mRNA CTD PMID:33387578 Rps6ka2 Mouse 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1348784 6480464 2,2',4,4',5-brominated diphenyl ether results in increased expression of RPS6KA2 mRNA CTD PMID:26705709 Rps6ka2 Mouse 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1348784 6480464 [bisphenol S co-treated with Fulvestrant] results in decreased methylation of RPS6KA2 gene CTD PMID:31601247 Rps6ka2 Mouse 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1348784 6480464 bisphenol S results in decreased methylation of RPS6KA2 gene CTD PMID:31601247 Rps6ka2 Mouse 4-hydroxynon-2-enal decreases expression ISO RGD:1348784 6480464 4-hydroxy-2-nonenal results in decreased expression of RPS6KA2 mRNA CTD PMID:12419474 Rps6ka2 Mouse 4-hydroxyphenyl retinamide increases phosphorylation ISO RGD:1348784 6480464 Fenretinide results in increased phosphorylation of RPS6KA2 protein CTD PMID:25246272 Rps6ka2 Mouse 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of RPS6KA2 mRNA CTD PMID:28973697 Rps6ka2 Mouse 4-hydroxyphenyl retinamide multiple interactions ISO RGD:1348784 6480464 U 0126 inhibits the reaction [Fenretinide results in increased phosphorylation of RPS6KA2 protein] CTD PMID:25246272 Rps6ka2 Mouse 5-aza-2'-deoxycytidine affects expression ISO RGD:1348784 6480464 Decitabine affects the expression of RPS6KA2 mRNA CTD PMID:23300844 Rps6ka2 Mouse 6-propyl-2-thiouracil increases expression ISO RGD:620676 6480464 Propylthiouracil results in increased expression of RPS6KA2 mRNA CTD PMID:24780913 Rps6ka2 Mouse acetamide increases expression ISO RGD:620676 6480464 acetamide results in increased expression of RPS6KA2 mRNA CTD PMID:31881176 Rps6ka2 Mouse acrolein multiple interactions ISO RGD:1348784 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... CTD PMID:32699268 Rps6ka2 Mouse aflatoxin B1 decreases expression ISO RGD:1348784 6480464 Aflatoxin B1 results in decreased expression of RPS6KA2 mRNA CTD PMID:22100608 Rps6ka2 Mouse aflatoxin B1 affects methylation ISO RGD:1348784 6480464 Aflatoxin B1 affects the methylation of RPS6KA2 intron CTD PMID:30157460 Rps6ka2 Mouse Aflatoxin B2 alpha increases methylation ISO RGD:1348784 6480464 aflatoxin B2 results in increased methylation of RPS6KA2 intron CTD PMID:30157460 Rps6ka2 Mouse alpha-pinene multiple interactions ISO RGD:1348784 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... CTD PMID:32699268 Rps6ka2 Mouse alpha-Zearalanol multiple interactions ISO RGD:620676 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RPS6KA2 mRNA CTD PMID:35163327 Rps6ka2 Mouse ammonium chloride affects expression ISO RGD:620676 6480464 Ammonium Chloride affects the expression of RPS6KA2 mRNA CTD PMID:16483693 Rps6ka2 Mouse aristolochic acid A decreases expression ISO RGD:1348784 6480464 aristolochic acid I results in decreased expression of RPS6KA2 mRNA CTD PMID:33212167 Rps6ka2 Mouse arsane affects methylation ISO RGD:1348784 6480464 Arsenic affects the methylation of RPS6KA2 gene CTD PMID:25304211 Rps6ka2 Mouse arsenic atom affects methylation ISO RGD:1348784 6480464 Arsenic affects the methylation of RPS6KA2 gene CTD PMID:25304211 Rps6ka2 Mouse atrazine decreases expression ISO RGD:1348784 6480464 Atrazine results in decreased expression of RPS6KA2 mRNA CTD PMID:22378314 Rps6ka2 Mouse benzo[a]pyrene multiple interactions EXP 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of RPS6KA2 mRNA]; Benzo(a)pyrene promotes the more ... CTD PMID:19654925|PMID:22228805 Rps6ka2 Mouse benzo[a]pyrene affects methylation ISO RGD:1348784 6480464 Benzo(a)pyrene affects the methylation of RPS6KA2 3' UTR; Benzo(a)pyrene affects the methylation of RPS6KA2 intron; more ... CTD PMID:27901495|PMID:30157460 Rps6ka2 Mouse benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of RPS6KA2 mRNA CTD PMID:22228805 Rps6ka2 Mouse benzo[a]pyrene decreases expression ISO RGD:1348784 6480464 Benzo(a)pyrene results in decreased expression of RPS6KA2 mRNA CTD PMID:20064835 Rps6ka2 Mouse benzo[a]pyrene increases mutagenesis ISO RGD:1348784 6480464 Benzo(a)pyrene results in increased mutagenesis of RPS6KA2 gene CTD PMID:25435355 Rps6ka2 Mouse benzo[e]pyrene affects methylation ISO RGD:1348784 6480464 benzo(e)pyrene affects the methylation of RPS6KA2 intron CTD PMID:30157460 Rps6ka2 Mouse beta-lapachone increases expression ISO RGD:1348784 6480464 beta-lapachone results in increased expression of RPS6KA2 mRNA CTD PMID:38218311 Rps6ka2 Mouse beta-naphthoflavone multiple interactions ISO RGD:620676 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of RPS6KA2 mRNA CTD PMID:18164116 Rps6ka2 Mouse bis(2-chloroethyl) sulfide increases expression EXP 6480464 Mustard Gas results in increased expression of RPS6KA2 mRNA CTD PMID:15674844 Rps6ka2 Mouse bisphenol A decreases expression ISO RGD:620676 6480464 bisphenol A results in decreased expression of RPS6KA2 mRNA CTD PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998 Rps6ka2 Mouse bisphenol A multiple interactions ISO RGD:1348784 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of RPS6KA2 gene CTD PMID:31601247 Rps6ka2 Mouse bisphenol A affects methylation ISO RGD:1348784 6480464 bisphenol A affects the methylation of RPS6KA2 gene CTD PMID:31601247 Rps6ka2 Mouse bisphenol A increases methylation ISO RGD:620676 6480464 bisphenol A results in increased methylation of RPS6KA2 gene CTD PMID:28505145 Rps6ka2 Mouse bisphenol A increases expression ISO RGD:1348784 6480464 bisphenol A results in increased expression of RPS6KA2 mRNA CTD PMID:29275510|PMID:36232920 Rps6ka2 Mouse butanal increases expression ISO RGD:1348784 6480464 butyraldehyde results in increased expression of RPS6KA2 mRNA CTD PMID:26079696 Rps6ka2 Mouse cadmium atom multiple interactions ISO RGD:1348784 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPS6KA2 more ... CTD PMID:35301059 Rps6ka2 Mouse cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPS6KA2 more ... CTD PMID:37325564 Rps6ka2 Mouse cadmium dichloride increases expression ISO RGD:620676 6480464 Cadmium Chloride results in increased expression of RPS6KA2 mRNA CTD PMID:33453195 Rps6ka2 Mouse cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPS6KA2 more ... CTD PMID:37325564 Rps6ka2 Mouse cadmium dichloride multiple interactions ISO RGD:1348784 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPS6KA2 more ... CTD PMID:35301059 Rps6ka2 Mouse cadmium dichloride decreases expression ISO RGD:1348784 6480464 Cadmium Chloride results in decreased expression of RPS6KA2 mRNA CTD PMID:38568856 Rps6ka2 Mouse cadmium dichloride increases expression ISO RGD:1348784 6480464 Cadmium Chloride results in increased expression of RPS6KA2 mRNA CTD PMID:38382870 Rps6ka2 Mouse cantharidin decreases expression EXP 6480464 Cantharidin results in decreased expression of RPS6KA2 mRNA CTD PMID:36907384 Rps6ka2 Mouse CGP 52608 multiple interactions ISO RGD:1348784 6480464 CGP 52608 promotes the reaction [RORA protein binds to RPS6KA2 gene] CTD PMID:28238834 Rps6ka2 Mouse chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of RPS6KA2 mRNA CTD PMID:37019170 Rps6ka2 Mouse cisplatin affects expression ISO RGD:1348784 6480464 Cisplatin affects the expression of RPS6KA2 mRNA CTD PMID:23300844 Rps6ka2 Mouse cisplatin decreases expression ISO RGD:1348784 6480464 Cisplatin results in decreased expression of RPS6KA2 mRNA CTD PMID:27392435 Rps6ka2 Mouse cisplatin multiple interactions ISO RGD:1348784 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of RPS6KA2 mRNA CTD PMID:27392435 Rps6ka2 Mouse cobalt dichloride decreases expression ISO RGD:1348784 6480464 cobaltous chloride results in decreased expression of RPS6KA2 mRNA CTD PMID:19320972 Rps6ka2 Mouse copper atom multiple interactions ISO RGD:1348784 6480464 [NSC 689534 binds to Copper] which results in increased expression of RPS6KA2 mRNA CTD PMID:20971185 Rps6ka2 Mouse copper(0) multiple interactions ISO RGD:1348784 6480464 [NSC 689534 binds to Copper] which results in increased expression of RPS6KA2 mRNA CTD PMID:20971185 Rps6ka2 Mouse copper(II) sulfate increases expression ISO RGD:1348784 6480464 Copper Sulfate results in increased expression of RPS6KA2 mRNA CTD PMID:20599845 Rps6ka2 Mouse Cuprizon increases expression ISO RGD:620676 6480464 Cuprizone results in increased expression of RPS6KA2 mRNA CTD PMID:26577399 Rps6ka2 Mouse cyclophosphamide affects response to substance ISO RGD:1348784 6480464 RPS6KA2 protein affects the susceptibility to Cyclophosphamide CTD PMID:16217747 Rps6ka2 Mouse cyclosporin A increases expression ISO RGD:1348784 6480464 Cyclosporine results in increased expression of RPS6KA2 mRNA CTD PMID:20106945|PMID:27989131 Rps6ka2 Mouse deoxynivalenol increases phosphorylation EXP 6480464 deoxynivalenol results in increased phosphorylation of RPS6KA2 protein CTD PMID:16424113 Rps6ka2 Mouse Dibutyl phosphate affects expression ISO RGD:1348784 6480464 di-n-butylphosphoric acid affects the expression of RPS6KA2 mRNA CTD PMID:37042841 Rps6ka2 Mouse dorsomorphin multiple interactions ISO RGD:1348784 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Rps6ka2 Mouse elemental selenium multiple interactions ISO RGD:1348784 6480464 [Selenium co-treated with Vitamin E] results in increased expression of RPS6KA2 mRNA CTD PMID:19244175 Rps6ka2 Mouse elemental selenium increases expression ISO RGD:1348784 6480464 Selenium results in increased expression of RPS6KA2 mRNA CTD PMID:19244175 Rps6ka2 Mouse endosulfan increases expression ISO RGD:620676 6480464 Endosulfan results in increased expression of RPS6KA2 mRNA CTD PMID:29391264 Rps6ka2 Mouse ethanol increases expression ISO RGD:1348784 6480464 Ethanol results in increased expression of RPS6KA2 mRNA CTD PMID:28986285 Rps6ka2 Mouse ethanol multiple interactions EXP 6480464 Ethanol affects the expression of and affects the splicing of RPS6KA2 mRNA CTD PMID:30319688 Rps6ka2 Mouse ferroheme b increases expression EXP 6480464 Heme metabolite results in increased expression of RPS6KA2 mRNA CTD PMID:19191707 Rps6ka2 Mouse fulvestrant decreases methylation ISO RGD:1348784 6480464 Fulvestrant results in decreased methylation of RPS6KA2 gene CTD PMID:31601247 Rps6ka2 Mouse fulvestrant multiple interactions ISO RGD:1348784 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of RPS6KA2 gene; [bisphenol S co-treated with more ... CTD PMID:31601247 Rps6ka2 Mouse heme b increases expression EXP 6480464 Heme metabolite results in increased expression of RPS6KA2 mRNA CTD PMID:19191707 Rps6ka2 Mouse hydroquinone increases expression ISO RGD:1348784 6480464 hydroquinone results in increased expression of RPS6KA2 mRNA CTD PMID:31256213 Rps6ka2 Mouse lead(0) affects splicing ISO RGD:1348784 6480464 Lead affects the splicing of RPS6KA2 mRNA CTD PMID:28903495 Rps6ka2 Mouse Licochalcone B decreases expression ISO RGD:1348784 6480464 licochalcone B results in decreased expression of RPS6KA2 mRNA CTD PMID:33647349 Rps6ka2 Mouse maneb multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] results in decreased expression of RPS6KA2 mRNA CTD PMID:18386188 Rps6ka2 Mouse metformin multiple interactions ISO RGD:1348784 6480464 [Metformin co-treated with Pioglitazone] results in increased expression of RPS6KA2 mRNA CTD PMID:32589349 Rps6ka2 Mouse metformin increases expression ISO RGD:1348784 6480464 Metformin results in increased expression of RPS6KA2 mRNA CTD PMID:32589349 Rps6ka2 Mouse methapyrilene affects methylation ISO RGD:1348784 6480464 Methapyrilene affects the methylation of RPS6KA2 intron CTD PMID:30157460 Rps6ka2 Mouse methoxychlor affects methylation ISO RGD:620676 6480464 Methoxychlor affects the methylation of RPS6KA2 gene CTD PMID:35440735 Rps6ka2 Mouse N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression ISO RGD:1348784 6480464 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of RPS6KA2 mRNA CTD PMID:19013360 Rps6ka2 Mouse N-nitrosodiethylamine multiple interactions ISO RGD:620676 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of RPS6KA2 mRNA CTD PMID:18164116 Rps6ka2 Mouse nitrogen mustard multiple interactions ISO RGD:1348784 6480464 caffeic acid phenethyl ester inhibits the reaction [Nitrogen Mustard Compounds results in increased phosphorylation of more ... CTD PMID:17204746 Rps6ka2 Mouse nitrogen mustard increases phosphorylation ISO RGD:1348784 6480464 Nitrogen Mustard Compounds results in increased phosphorylation of RPS6KA2 protein CTD PMID:17204746 Rps6ka2 Mouse Nor-9-carboxy-delta9-THC multiple interactions ISO RGD:1348784 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of RPS6KA2 gene CTD PMID:30521419 Rps6ka2 Mouse obeticholic acid increases expression ISO RGD:1348784 6480464 obeticholic acid results in increased expression of RPS6KA2 mRNA CTD PMID:27939613 Rps6ka2 Mouse okadaic acid decreases expression ISO RGD:1348784 6480464 Okadaic Acid results in decreased expression of RPS6KA2 mRNA CTD PMID:38832940 Rps6ka2 Mouse ozone decreases expression EXP 6480464 Ozone results in decreased expression of RPS6KA2 mRNA CTD PMID:12763052 Rps6ka2 Mouse ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased more ... CTD PMID:34911549 Rps6ka2 Mouse ozone multiple interactions ISO RGD:1348784 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... CTD PMID:32699268 Rps6ka2 Mouse paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of RPS6KA2 mRNA CTD PMID:17562736 Rps6ka2 Mouse paracetamol increases expression ISO RGD:620676 6480464 Acetaminophen results in increased expression of RPS6KA2 mRNA CTD PMID:33387578 Rps6ka2 Mouse paracetamol decreases expression ISO RGD:1348784 6480464 Acetaminophen results in decreased expression of RPS6KA2 mRNA CTD PMID:38614205 Rps6ka2 Mouse paracetamol increases expression ISO RGD:1348784 6480464 Acetaminophen results in increased expression of RPS6KA2 mRNA CTD PMID:29067470 Rps6ka2 Mouse paraquat multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] results in decreased expression of RPS6KA2 mRNA CTD PMID:18386188 Rps6ka2 Mouse pentanal increases expression ISO RGD:1348784 6480464 pentanal results in increased expression of RPS6KA2 mRNA CTD PMID:26079696 Rps6ka2 Mouse perfluorohexanesulfonic acid decreases expression EXP 6480464 perfluorohexanesulfonic acid results in decreased expression of RPS6KA2 mRNA CTD PMID:37995155 Rps6ka2 Mouse perfluorooctanoic acid multiple interactions ISO RGD:620676 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RPS6KA2 mRNA CTD PMID:35163327 Rps6ka2 Mouse phenethyl caffeate multiple interactions ISO RGD:1348784 6480464 caffeic acid phenethyl ester inhibits the reaction [Mustard Compounds results in increased phosphorylation of RPS6KA2 more ... CTD PMID:17204746 Rps6ka2 Mouse phenylmercury acetate increases expression ISO RGD:1348784 6480464 Phenylmercuric Acetate results in increased expression of RPS6KA2 mRNA CTD PMID:26272509 Rps6ka2 Mouse phenylmercury acetate multiple interactions ISO RGD:1348784 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Rps6ka2 Mouse phosgene affects expression EXP 6480464 Phosgene affects the expression of RPS6KA2 mRNA CTD PMID:16300373 Rps6ka2 Mouse pioglitazone multiple interactions ISO RGD:1348784 6480464 [Metformin co-treated with Pioglitazone] results in increased expression of RPS6KA2 mRNA CTD PMID:32589349 Rps6ka2 Mouse pioglitazone increases expression ISO RGD:1348784 6480464 Pioglitazone results in increased expression of RPS6KA2 mRNA CTD PMID:32589349 Rps6ka2 Mouse potassium chromate decreases expression ISO RGD:1348784 6480464 potassium chromate(VI) results in decreased expression of RPS6KA2 mRNA CTD PMID:22714537 Rps6ka2 Mouse propanal increases expression ISO RGD:1348784 6480464 propionaldehyde results in increased expression of RPS6KA2 mRNA CTD PMID:26079696 Rps6ka2 Mouse raloxifene multiple interactions ISO RGD:1348784 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of RPS6KA2 mRNA CTD PMID:19059307 Rps6ka2 Mouse SB 431542 multiple interactions ISO RGD:1348784 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Rps6ka2 Mouse selenium atom multiple interactions ISO RGD:1348784 6480464 [Selenium co-treated with Vitamin E] results in increased expression of RPS6KA2 mRNA CTD PMID:19244175 Rps6ka2 Mouse selenium atom increases expression ISO RGD:1348784 6480464 Selenium results in increased expression of RPS6KA2 mRNA CTD PMID:19244175 Rps6ka2 Mouse silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of RPS6KA2 mRNA CTD PMID:29203145 Rps6ka2 Mouse sirolimus affects localization EXP 6480464 Sirolimus affects the localization of RPS6KA2 protein CTD PMID:19151764 Rps6ka2 Mouse sirolimus increases phosphorylation EXP 6480464 Sirolimus results in increased phosphorylation of RPS6KA2 protein CTD PMID:19151764 Rps6ka2 Mouse sodium arsenite multiple interactions ISO RGD:1348784 6480464 sodium arsenite results in decreased expression of and affects the splicing of RPS6KA2 mRNA CTD PMID:25879800 Rps6ka2 Mouse sodium arsenite decreases expression ISO RGD:1348784 6480464 sodium arsenite results in decreased expression of RPS6KA2 mRNA CTD PMID:34032870 Rps6ka2 Mouse sodium arsenite increases expression ISO RGD:1348784 6480464 sodium arsenite results in increased expression of RPS6KA2 mRNA CTD PMID:38568856 Rps6ka2 Mouse sodium arsenite affects methylation ISO RGD:1348784 6480464 sodium arsenite affects the methylation of RPS6KA2 gene CTD PMID:28589171 Rps6ka2 Mouse succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RPS6KA2 mRNA CTD PMID:21641980 Rps6ka2 Mouse sunitinib increases expression ISO RGD:1348784 6480464 Sunitinib results in increased expression of RPS6KA2 mRNA CTD PMID:31533062 Rps6ka2 Mouse tamoxifen multiple interactions ISO RGD:1348784 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of RPS6KA2 mRNA CTD PMID:19059307 Rps6ka2 Mouse tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of RPS6KA2 mRNA CTD PMID:17555576 Rps6ka2 Mouse taurine increases expression ISO RGD:1348784 6480464 Taurine results in increased expression of RPS6KA2 mRNA CTD PMID:16579726 Rps6ka2 Mouse tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of RPS6KA2 mRNA CTD PMID:17484886 Rps6ka2 Mouse tetracycline increases expression EXP 6480464 Tetracycline results in increased expression of RPS6KA2 mRNA CTD PMID:16917069 Rps6ka2 Mouse thalidomide decreases expression EXP 6480464 Thalidomide results in decreased expression of RPS6KA2 mRNA CTD PMID:26217789 Rps6ka2 Mouse thioacetamide increases expression ISO RGD:620676 6480464 Thioacetamide results in increased expression of RPS6KA2 mRNA CTD PMID:34492290 Rps6ka2 Mouse thiram decreases expression ISO RGD:1348784 6480464 Thiram results in decreased expression of RPS6KA2 mRNA CTD PMID:38568856 Rps6ka2 Mouse titanium dioxide decreases methylation EXP 6480464 titanium dioxide results in decreased methylation of RPS6KA2 gene; titanium dioxide results in decreased methylation more ... CTD PMID:35295148 Rps6ka2 Mouse trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of RPS6KA2 mRNA CTD PMID:35537566 Rps6ka2 Mouse valproic acid affects expression ISO RGD:1348784 6480464 Valproic Acid affects the expression of RPS6KA2 mRNA CTD PMID:25979313 Rps6ka2 Mouse valproic acid increases expression ISO RGD:1348784 6480464 Valproic Acid results in increased expression of RPS6KA2 mRNA CTD PMID:23179753|PMID:24383497|PMID:24935251|PMID:28001369 Rps6ka2 Mouse vitamin E multiple interactions ISO RGD:1348784 6480464 [Selenium co-treated with Vitamin E] results in increased expression of RPS6KA2 mRNA CTD PMID:19244175 Rps6ka2 Mouse zinc sulfate increases expression ISO RGD:1348784 6480464 Zinc Sulfate results in increased expression of RPS6KA2 mRNA CTD PMID:19013360